Monday, December 23, 2024
HomeTagsACE1831

ACE1831

Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic gamma delta T-cell Therapy

Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) platform technology to address gaps in cancer care, announced...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics